Home > National Drug Code (NDC) > Treatment Set TS333312

Treatment Set TS333312 - 49288-0667-3 - (Treatment Set TS333312)

Alphabetical Index


Drug Information of Treatment Set TS333312

Product NDC: 49288-0667
Proprietary Name: Treatment Set TS333312
Non Proprietary Name: Treatment Set TS333312
Active Ingredient(s): .01; .002; 80; .01; 800; .01    g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS333312
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS333312

Product NDC: 49288-0667
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 20091218

Package Information of Treatment Set TS333312

Package NDC: 49288-0667-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0667-3)

NDC Information of Treatment Set TS333312

NDC Code 49288-0667-3
Proprietary Name Treatment Set TS333312
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0667-3)
Product NDC 49288-0667
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS333312
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 20091218
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER NEGUNDO POLLEN; ALTERNARIA ALTERNATA; CYNODON DACTYLON POLLEN; FRAXINUS AMERICANA POLLEN; PHLEUM PRATENSE POLLEN; PLATANUS OCCIDENTALIS POLLEN
Strength Number .01; .002; 80; .01; 800; .01
Strength Unit g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS333312


General Information